Industry Encouraged By FDA Fulfillment Of MDUFA 2013 Goals
Executive Summary
AdvaMed is pleased FDA met its review and performance goals for fiscal year 2013 as outlined in the October 2012 medical device user fee agreement.
You may also be interested in...
CDRH Sequestration Impact: Training, Standards And Reg Science
CDRH Director Jeffrey Shuren detailed last week how federal sequestration cuts to FDA are impacting specific device center programs, including training, standards development and regulatory science. Shuren also signaled imminent policy releases from the center, including a finalized post-market surveillance plan.
FDA Subject To More Oversight Following User Fee Bill Passage
The legislation, awaiting the signature of the president, will bring greater scrutiny of device center activities by Congress and industry.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”